PREPRINT (not peer reviewed)
Low doses of psilocybin as adjunct pharmacological treatment to virtual reality exposure therapy for social anxiety disorder: A study protocol for a double-blind randomized controlled trial.
An abstract is available from the original source but is not redistributed by this tracker. Read the source record.